B Vitamins for Migraine Prophylaxis
B vitamins are not recommended as first-line therapy for migraine prevention according to the most recent 2025 American College of Physicians guidelines, which do not include them among evidence-based pharmacologic treatments. 1
Guideline-Based Recommendations
First-Line Treatments (Not B Vitamins)
The 2025 ACP guidelines establish a clear hierarchy for migraine prophylaxis that prioritizes:
- Beta-blockers (metoprolol, propranolol), valproate, venlafaxine, or amitriptyline as initial therapy 1
- CGRP antagonists (atogepant, rimegepant) or CGRP monoclonal antibodies (eptinezumab, erenumab, fremanezumab, galcanezumab) as second-line options 1
- ARBs (candesartan, telmisartan), ACE inhibitors (lisinopril), or SSRIs (fluoxetine) if first-line treatments fail 1
B vitamins are conspicuously absent from these evidence-based recommendations, indicating insufficient comparative effectiveness data to support their routine use. 1
Where B Vitamins Stand in Current Guidelines
The 2025 international migraine treatment guidelines similarly do not include B vitamins among recommended pharmacologic preventive treatments, focusing instead on established medications with robust evidence. 2
Research Evidence on B Vitamins (Secondary Consideration)
While guidelines do not recommend B vitamins, research studies suggest potential benefits that may warrant consideration in specific clinical contexts:
Riboflavin (Vitamin B2) - Strongest Evidence
- Riboflavin 400 mg daily for 3 months significantly reduces migraine days, duration, frequency, and pain scores in adults 3
- The 2025 systematic review confirms riboflavin can be recommended for adult migraine prevention with minimal adverse events, though pediatric evidence remains insufficient 4
- Riboflavin receives Level C evidence (may be effective) for migraine prevention with low adverse event profile 4
Combination B Vitamins
- A 2022 RCT demonstrated that B1, B6, B9 (folic acid), B12, and B-complex combinations all significantly reduced headache frequency and disability scores compared to placebo in women with episodic migraine 5
- The combination of B6 with folate and B12 shows significant benefits for migraine with aura prophylaxis in adults across five RCTs 6
- B6 alone or combined with folate demonstrates efficacy for migraine with aura prevention 6
- Folate supplementation alone was not more efficacious than placebo 6
Clinical Context for B Vitamin Use
B vitamins may be considered as adjunctive therapy or in patients who:
- Cannot tolerate or have contraindications to guideline-recommended first-line agents 7
- Prefer natural or less costly supplementation strategies 7
- Have documented hyperhomocysteinemia or suspected mitochondrial energy deficits 7, 6
Practical Regimen (If Choosing B Vitamins Despite Guideline Absence)
If you elect to use B vitamins after exhausting guideline-recommended options:
- Riboflavin 400 mg daily for at least 3 months 3, 4
- Consider adding B6, B9 (folic acid), and B12 as combination therapy, particularly for migraine with aura 5, 6
- Expect minimal adverse events, primarily mild gastrointestinal symptoms 6, 4
- Monitor response over 2-3 months, consistent with standard migraine prevention trial periods 1
Critical Caveats
The absence of B vitamins from major 2025 guidelines reflects:
- Lack of head-to-head comparative effectiveness data against established preventive medications 1
- Smaller sample sizes and methodological limitations in available RCTs 6
- Insufficient evidence to establish them as first-line therapy over proven pharmacologic agents 1
Do not substitute B vitamins for guideline-recommended first-line treatments in patients with severe, debilitating migraine requiring robust prophylaxis. 1, 8
B vitamins should not be used for acute migraine treatment, as one RCT and one prospective trial showed no benefit in managing acute attacks. 6